Cite
HARVARD Citation
Ding, X. et al. (2017). Genetic characterization drives personalized therapy for early-stage non-small-cell lung cancer (NSCLC) patients and survivors with metachronous second primary tumor (MST). Medicine. 96 (10), p. . [Online].